✕
Login
Register
Back to News
Barclays Maintains Overweight on Repligen, Raises Price Target to $160
Benzinga Newsdesk
www.benzinga.com
Positive 92.0%
Neg 0%
Neu 0%
Pos 92%
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment